Moxnidazole

CAS No. 52279-59-1

Moxnidazole( —— )

Catalog No. M36201 CAS No. 52279-59-1

Moxnidazole, a 5-nitroimidazole, is mutagenic in microbial assays and in Drosophila, inducing genetic alterations in mouse somatic cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 290 Get Quote
5MG 447 Get Quote
10MG 655 Get Quote
25MG 994 Get Quote
50MG 1343 Get Quote
100MG 1764 Get Quote
500MG 3537 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Moxnidazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Moxnidazole, a 5-nitroimidazole, is mutagenic in microbial assays and in Drosophila, inducing genetic alterations in mouse somatic cells.
  • Description
    Moxnidazole, a 5-nitroimidazole, is mutagenic in microbial assays and in Drosophila, inducing genetic alterations in mouse somatic cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    52279-59-1
  • Formula Weight
    338.32
  • Molecular Formula
    C13H18N6O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(=CC=1N(C)C(N(=O)=O)=CN1)N2CC(CN3CCOCC3)OC2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-OMFP Cyclohexylamm...

    3-OMFP Cyclohexylammonium salt (OMFP Cyclohexylammonium salt) is a substrate for PTEN inhibition studies and can be used to measure enzyme activity in the catalytic structural domain of CDC25B.

  • CRT-0105950

    CRT-0105950 is a potent LIMK inhibitor with high affinity for both LIMK1 and LIMK2.CRT-0105950 inhibits filamentous cutin phosphorylation and promotes α-microtubulin acetylation in cells.

  • 26Rfa, Hypothalamic ...

    This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.